financetom
Business
financetom
/
Business
/
Celsius Strikes $1.8 Billion Deal to Buy Energy Drink Maker Alani Nutrition
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Celsius Strikes $1.8 Billion Deal to Buy Energy Drink Maker Alani Nutrition
Feb 21, 2025 3:59 AM

06:35 AM EST, 02/21/2025 (MT Newswires) -- Celsius Holdings ( CELH ) shares spiked early Friday as the company agreed to acquire energy drink maker Alani Nutrition in a cash-and-stock deal worth about $1.8 billion to expand its category portfolio and reach.

The company, which owns the Celsius energy drink brand, will purchase Alani Nutrition from its co-founders Katy Schneider and Haydn Schneider and its operator, Congo Brands, for $1.8 billion, it said late Thursday. The transaction includes about $150 million in tax assets, resulting in a net purchase price of $1.65 billion, according to Celsius.

The deal consists of $1.28 billion in cash, including $900 million in debt financing, a potential $25 million earn-out based on performance this year and $500 million of newly issued restricted shares of Celsius, representing a roughly 8.7% pro-forma ownership, the company said. The transaction, which requires approval from regulators, is expected to complete in the second quarter.

Shares of Celsius jumped 31% in the most recent premarket activity.

"Celsius is at a defining moment in the better-for-you, functional lifestyle products movement, and we are thrilled to welcome Alani Nu to the Celsius family," Celsius Chief Executive John Fieldly said in a statement. "Together, we expect to broaden the availability of Alani Nu's functional products to help more people achieve their wellness goals."

Celsius forecasts the acquisition to boost its position in the global energy category and drive about $2 billion in sales across its combined portfolio. The company estimates the deal to be accretive to cash earnings in the first full year of ownership on a per-share basis and generate $50 million of cost synergies over two years after completion.

"We believe Celsius can unlock key growth opportunities for Alani Nu," Congo Brands co-CEO Max Clemons said in the statement. The company will operate within Celsius after its acquisition, while important members of Congo Brands' leadership team will continue to serve as advisers.

In a separate statement, Celsius reported fourth-quarter adjusted earnings of $0.14 a share, down from $0.17 the year before, but ahead of the FactSet-polled consensus of $0.12. Revenue declined 4% year over year to $332.2 million, but topped the Street's view for $326.2 million.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Ousted Ben & Jerry's board chair sues Unilever, alleging defamation
Ousted Ben & Jerry's board chair sues Unilever, alleging defamation
Mar 26, 2026
March 26 (Reuters) - Unilever ( UL ) and its recently spun-off Magnum ice cream unit were sued for defamation on Thursday by Anuradha Mittal, who was ousted in December as chair of Ben & Jerry's ( UL ) independent board, saying the companies vilified and discredited her for supporting Palestinian rights. The lawsuit escalates a years-long dispute over what...
US FDA approves Novo's insulin injection for type 2 diabetes
US FDA approves Novo's insulin injection for type 2 diabetes
Mar 26, 2026
March 26 (Reuters) - The U.S. Food and Drug Administration has approved Novo Nordisk's insulin injection, Awiqli, to control blood sugar levels in adults living with type 2 diabetes, the company said on Thursday. * Novo Nordisk expects to launch the insulin product in the United States in the second half of 2026. * The Danish drugmaker said its product...
US FDA approves Novo's insulin injection for type 2 diabetes
US FDA approves Novo's insulin injection for type 2 diabetes
Mar 26, 2026
March 26 (Reuters) - The U.S. Food and Drug Administration (FDA) has approved Novo Nordisk's insulin injection, Awiqli, to improve blood sugar levels in adults living with type 2 diabetes, the company said on Thursday. ...
Ousted Ben & Jerry's board chair sues Unilever, alleging defamation
Ousted Ben & Jerry's board chair sues Unilever, alleging defamation
Mar 26, 2026
* Mittal says Unilever ( UL ) rankled by her support for Palestinian rights * Ben & Jerry's ( UL ) has battled Unilever ( UL ) since 2021 * Unilever ( UL ) not available for comment, Magnum calls claims unfounded (Recasts first paragraph; adds Magnum comment, details from complaint, background, paragraphs 2-3, 6, 8, 10-14) By Jonathan Stempel...
Copyright 2023-2026 - www.financetom.com All Rights Reserved